Involvement of Heparanase in early pregnancy losses

Thrombosis Research

Volumn 125, Issue 5, 2010, Pages

  Nadir, Yona ^a   Henig, Israel ^a   Naroditzky, Inna ^b   Paz, Baram ^c   Vlodavsky, Israel ^d   Brenner, Benjamin ^a  

^a RAMBAM MEDICAL CENTER   (Israel)

^b Department of Pathology ^*  (Israel)

^c BNAI ZION MEDICAL CENTER   (Israel)

^d TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Heparanase; Miscarriage; TFPI 2; Thrombophilia

Indexed keywords

HEPARANASE; PLACENTA PROTEIN 5; THROMBOPLASTIN; TISSUE FACTOR PATHWAY INHIBITOR; VASCULOTROPIN A;

ADULT; ARTICLE; CELL SURFACE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; PLACENTA; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPONTANEOUS ABORTION; THROMBOPHILIA; TROPHOBLAST; UPREGULATION;

ABORTION, SPONTANEOUS; ADULT; CYTOKINES; FEMALE; GLUCURONIDASE; HUMANS; PLACENTA; PREGNANCY; YOUNG ADULT;

EID: 77951666545     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2009.11.026     Document Type: Article

References (34)

1. Lanir N., Aharon A., and Brenner B. Procoagulant and anticoagulant mechanisms in human placenta. Semin Thromb Hemost 29 (2003) 175-184
2. Freeman C., and Parish C.R. Human platelet heparanase: purification, characterization and catalytic activity. Biochem J 330 (1998) 1341-1350
3. Pikas D.S., Li J.P., Vlodavsky I., and Lindahl U. Substrate specificity of heparanases from human hepatoma and platelets. J Biol Chem 273 (1998) 18770-18777
4. Parish C.R., Freeman C., and Hulett M.D. Heparanase: a key enzyme involved in cell invasion. Biochim Biophys Acta 1471 (2001) M99-108
5. Vlodavsky I., and Friedmann Y. Molecular properties and involvement of heparanase in cancer metastasis and angiogenesis. J Clin Invest 108 (2001) 341-347
6. Goldshmidt O., Zcharia E., Aingorn H., Guatta-Rangini Z., Atzmon R., Michal I., et al. Expression pattern and secretion of human and chicken heparanase are determined by their signal peptide sequence. J Biol Chem 276 (2001) 29178-29187
7. Dempsey L.A., Brunn G.J., and Platt J.L. Heparanase, a potential regulator of cell-matrix interactions. Trends Biochem Sci 25 (2000) 349-351
8. Hulett M.D., Freeman C., Hamdorf B.J., Baker R.T., Harris M.J., and Parish C.R. Cloning of mammalian heparanase, an important enzyme in tumor invasion and metastasis. Nat Med 5 (1999) 803-809
9. Kussie P.H., Hulmes J.D., Ludwig D.L., Patel S., Navarro E.C., Seddon A.P., et al. Cloning and functional expression of a human heparanase gene. Biochem Biophys Res Commun 261 (1999) 183-187
10. Toyoshima M., and Nakajima M. Human heparanase. Purification, characterization, cloning, and expression. J Biol Chem 274 (1999) 24153-24160
11. Vlodavsky I., Friedmann Y., Elkin M., Aingorn H., Atzmon R., Ishai-Michaeli R., et al. Mammalian heparanase: gene cloning, expression and function in tumor progression and metastasis. Nat Med 5 (1999) 793-802
12. Goldshmidt O., Zcharia E., Cohen M., Aingorn H., Cohen I., Nadav L., et al. Heparanase mediates cell adhesion independent of its enzymatic activity. Faseb J 17 (2003) 1015-1025
13. Gingis-Velitski S., Zetser A., Flugelman M.Y., Vlodavsky I., and Ilan N. Heparanase induces endothelial cell migration via protein kinase B/Akt activation. J Biol Chem 279 (2004) 23536-23541
14. Zetser A., Bashenko Y., Edovitsky E., Levy-Adam F., Vlodavsky I., and Ilan N. Heparanase induces vascular endothelial growth factor expression: correlation with p38 phosphorylation levels and Src activation. Cancer Res 66 (2006) 1455-1463
15. Nadir Y., Brenner B., Zetser A., Ilan N., Shafat I., Zcharia E., et al. Heparanase induces tissue factor expression in vascular endothelial and cancer cells. J Thromb Haemost 4 (2006) 2443-2451
16. Nadir Y., Brenner B., Gingis-Velitski S., Levy-Adam F., Ilan N., Zcharia E., et al. Heparanase induces tissue factor pathway inhibitor expression and extracellular accumulation in endothelial and tumor cells. Thromb Haemost 99 (2008) 133-141
17. Gingis-Velitski S., Zetser A., Kaplan V., Ben-Zaken O., Cohen E., Levy-Adam F., et al. Heparanase Uptake Is Mediated by Cell Membrane Heparan Sulfate Proteoglycans. J Biol Chem 279 (2004) 44084-44092
18. Zetser A., Bashenko Y., Miao H.-Q., Vlodavsky I., and Ilan N. Heparanase Affects Adhesive and Tumorigenic Potential of Human Glioma Cells. Cancer Res 63 (2003) 7733-7741
19. Zetser A., Levy-Adam F., Kaplan V., Gingis-Velitski S., Bashenko Y., Schubert S., et al. Processing and activation of latent heparanase occurs in lysosomes. J Cell Sci 117 (2004) 2249-2225
20. Nardella C., Lahm A., Pallaoro M., Brunetti M., Vannini A., and Steinkuhler C. Mechanism of activation of human heparanase investigated by protein engineering. Biochemistry 43 (2004) 1862-1873
21. Argani P., Zakowski M.F., Klimstra D.S., Rosai J., and Ladanyi M. Detection of the SYT-SSX chimeric RNA of synovial sarcoma in paraffin-embedded tissue and its application in problematic cases. Mod Pathol 11 (1998) 65-71
22. Haimov-Kochman R., Friedmann Y., Prus D., Goldman-Wohl D.S., Greenfield C., Anteby E.Y., et al. Localization of heparanase in normal and pathological human placenta. Mol Hum Reprod 8 (2002) 566-573
23. Goshen R., Hochberg A.A., Korner G., Levy E., Ishai-Michaeli R., Elkin M., et al. Purification and characterization of placental heparanase and its expression by cultured cytotrophoblasts. Mol Hum Reprod 2 (1996) 679-684
24. Udagawa K., Yasumitsu H., Esaki M., Sawada H., Nagashima Y., Aoki I., et al. Subcellular localization of PP5/TFPI-2 in human placenta: a possible role of PP5/TFPI-2 as an anti-coagulant on the surface of syncytiotrophoblasts. Placenta 23 (2002) 145-153
25. Herman M.P., Sukhova G.K., Kisiel W., Foster D., Kehry M.R., Libby P., et al. Tissue factor pathway inhibitor-2 is a novel inhibitor of matrix metalloproteinases with implications for atherosclerosis. J Clin Invest 107 (2001) 1117-1126
26. Salem H.T., Westergaard J.G., Hindersson P., Lee J.N., Grudzinskas J.G., and Chard T. Maternal serum levels of placental protein 5 in complications of late pregnancy. Obstet Gynecol 59 (1982) 467-471
27. Sgambati E., and Marini M. Zappoli Thyrion GD, Parretti E, Mello G, Orlando C, Simi L, Tricarico C, Gheri G, Brizzi E: VEGF expression in the placenta from pregnancies complicated by hypertensive disorders. BJOG 111 (2004) 564-570
28. Geva E., Ginzinger D.G., Zaloudek C.J., Moore D.H., Byrne A., and Jaffe R.B. Human placental vascular development: vasculogenic and angiogenic (branching and nonbranching) transformation is regulated by vascular endothelial growth factor-A, angiopoietin-1, and angiopoietin-2. J Clin Endocrinol Metab 87 (2002) 4213-4224
29. Brogi E., Wu T., Namiki A., and Isner J.M. Indirect angiogenic cytokines upregulate VEGF and bFGF gene expression in vascular smooth muscle cells, whereas hypoxia upregulates VEGF expression only. Circulation 90 (1994) 649-652
30. Aharon A., Brenner B., Katz T., Miyagi Y., and Lanir N. Tissue factor and tissue factor pathway inhibitor levels in trophoblast cells: implications for placental hemostasis. Thromb Haemost 92 (2004) 776-786
31. Aharon A., Katzenell S., Tamari T., and Brenner B. Tissue factor- and tissue factor pathway inhibitor-bearing microparticles in gestational vascular complications. J Thromb Haemost 7 (2009) 1047-1050
32. Xu X., Ding J., Rao G., Shen J., Prinz R.A., Rana N., et al. Estradiol induces heparanase-1 expression and heparan sulphate proteoglycan degradation in human endometrium. Hum Reprod 22 (2007) 927-937
33. Elkin M., Cohen I., Zcharia E., Orgel A., Guatta-Rangini Z., Peretz T., et al. Regulation of heparanase gene expression by estrogen in breast cancer. Cancer Res 63 (2003) 8821-8826
34. Ostrovsky O., Korostishevsky M., Levite I., Leiba M., Galski H., Vlodavsky I., et al. Association of heparanase gene (HPSE) single nucleotide polymorphisms with hematological malignancies. Leukemia 21 (2007) 2296-2303